Provenance du réseau au premier degré de Kaspar Cottier
Entité | Type d'entité | Industrie | |
---|---|---|---|
Creoptix AG
Creoptix AG BiotechnologyHealth Technology Creoptix AG provides biosensor devices for applications in drug discovery. It specializes in optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery. The firm’s products include instruments, sensors, and software. The company was founded by Kaspar Cottier in 2009 and is headquartered in Wadenswil, Switzerland.
5
| Subsidiary | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kaspar Cottier via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
METTLER-TOLEDO INTERNATIONAL, INC. | Medical Specialties | Corporate Officer/Principal | |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Director/Board Member | |
MycoTechnology, Inc.
MycoTechnology, Inc. Food: Major DiversifiedConsumer Non-Durables MycoTechnology, Inc. is a food technology company, which engages in the development and delivering of fermentation process using gourmet fungi to transform agricultural products to improve taste, value, and health. Its products include ClearTaste and PureTaste. The company was founded by Alan D. Hahn, Pete Lubar, Jim Langan, and Brooks J. Kelly in 2013 and is headquartered in Aurora, CO. | Food: Major Diversified | Director/Board Member | |
MORPHOSYS AG | Biotechnology | Corporate Officer/Principal | |
UBS Warburg (Switzerland)
UBS Warburg (Switzerland) Investment Banks/BrokersFinance Part of UBS Group AG, UBS Warburg (Switzerland) provides investment banking and securities services. | Investment Banks/Brokers | Corporate Officer/Principal | |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Private Equity Investor | |
Mettler-Toledo Rainin LLC
Mettler-Toledo Rainin LLC Electronic Equipment/InstrumentsElectronic Technology Mettler-Toledo Rainin LLC develops, manufactures and distributes pipetting solutions used in pharmaceutical, biotech and medical research applications. It offers single channel manual pipettes, speciality pipetts, high-throughout pipetting. The company is headquartered in Oakland, CA. | Electronic Equipment/Instruments | Sales & Marketing | |
University of Vienna | College/University | Doctorate Degree | |
University of St. Gallen | College/University | Masters Business Admin | |
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London. | Investment Managers | Investment Committee Member | |
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
London School of Economics & Political Science | College/University | Graduate Degree | |
University of Basel | College/University | Undergraduate Degree | |
University of Zurich | College/University | Doctorate Degree | |
University of Lausanne | College/University | Graduate Degree | |
ImmunoBiology Ltd.
ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | President | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
European University Viadrina Frankfurt | College/University | Masters Business Admin | |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Packaged Software | Director/Board Member | |
Connova AG
Connova AG SemiconductorsElectronic Technology Connova AG provides composite components. It offers services to the logistics, engineering and hospitality sectors. The firm provides finishing, assembling and post-processing services. The company is headquartered in Zurich, Switzerland. | Semiconductors | Chief Executive Officer | |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Director/Board Member | |
Medimaps Group SA
Medimaps Group SA Packaged SoftwareTechnology Services Medimaps Group SA designs and provides medical tools. The company is headquartered in Plan-les-Ouates, Switzerland. | Packaged Software | Director/Board Member | |
Bridging Minds SARL | Chief Executive Officer | ||
Memo Therapeutics AG
Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Suisse | 13 |
Etats-Unis | 7 |
Allemagne | 5 |
Royaume-Uni | 4 |
Pays-Bas | 3 |
Sectorielle
Health Technology | 13 |
Consumer Services | 8 |
Finance | 4 |
Electronic Technology | 3 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 15 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 3 |
Graduate Degree | 3 |
Masters Business Admin | 2 |
Relations les plus connectées
Insiders | |
---|---|
Robert Schier | 20 |
Jon Andri Jörg | 7 |
Mátyás Végh | 6 |
Line Stigen Raquet | 1 |
Mathias Antener | 1 |
- Bourse
- Insiders
- Kaspar Cottier
- Connexions Sociétés